| Date | Time | Source | Headline | Symbol | Company |
| 05/02/2024 | 8:00AM | GlobeNewswire Inc. | PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 | NASDAQ:PRPH | ProPhase Labs Inc |
| 04/25/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 04/16/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Unveils Project ZenQ-AI | NASDAQ:PRPH | ProPhase Labs Inc |
| 04/10/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 04/01/2024 | 9:00PM | GlobeNewswire Inc. | ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRPH | ProPhase Labs Inc |
| 03/15/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives | NASDAQ:PRPH | ProPhase Labs Inc |
| 03/08/2024 | 8:00AM | GlobeNewswire Inc. | PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 02/20/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART | NASDAQ:PRPH | ProPhase Labs Inc |
| 02/14/2024 | 4:05PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:PRPH | ProPhase Labs Inc |
| 02/14/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir | NASDAQ:PRPH | ProPhase Labs Inc |
| 01/30/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics | NASDAQ:PRPH | ProPhase Labs Inc |
| 01/23/2024 | 8:00AM | GlobeNewswire Inc. | Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts | NASDAQ:PRPH | ProPhase Labs Inc |
| 01/04/2024 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRPH | ProPhase Labs Inc |
| 01/04/2024 | 8:00AM | GlobeNewswire Inc. | ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024 | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/13/2023 | 4:04PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/09/2023 | 8:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/09/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023 | NASDAQ:PRPH | ProPhase Labs Inc |
| 11/02/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time | NASDAQ:PRPH | ProPhase Labs Inc |
| 10/17/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output. | NASDAQ:PRPH | ProPhase Labs Inc |
| 10/12/2023 | 8:25AM | GlobeNewswire Inc. | DSS Inc. Issues Letter to Shareholders | NASDAQ:PRPH | ProPhase Labs Inc |
| 10/12/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs to Present at The ThinkEquity Conference | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/11/2023 | 4:10PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/10/2023 | 10:40AM | GlobeNewswire Inc. | ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call. | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/10/2023 | 8:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/10/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023 | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/03/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound | NASDAQ:PRPH | ProPhase Labs Inc |
| 08/02/2023 | 8:00AM | GlobeNewswire Inc. | ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time | NASDAQ:PRPH | ProPhase Labs Inc |
| 06/29/2023 | 8:05AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRPH | ProPhase Labs Inc |
| 06/29/2023 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PRPH | ProPhase Labs Inc |
| 06/29/2023 | 8:00AM | GlobeNewswire Inc. | Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea | NASDAQ:PRPH | ProPhase Labs Inc |